An Alzheimer's drug deemed the "best ever" is set to be blocked for NHS use due to its high cost. Donanemab, manufactured by ...

Donanemab has been described as a game-changer for Alzheimer's, with research showing it slowed its progressions by 35 per ...

A message from Sir Keir Starmer features on the front of the Daily Mirror, which says he promised winners of the Pride of ...

U.K. regulators will reportedly recommend the NHS not cover Eli Lilly’s (LLY) donanemab for the treatment of early ...

Alzheimer’s patients are set to find out whether a new drug could become available in the UK as health regulators are poised ...

The most effective drug for Alzheimer’s will be blocked for use on the NHS on Wednesday. Regulators are expected to declare ...

Britain's National Health Service (NHS) will block Eli Lilly's Alzheimer's drug donanemab on Wednesday, deeming it too ...

In late 2022, the results of a groundbreaking stage three trial for a ‘miracle’ new Alzheimer’s drug lecanemab were hailed as ...

VALPARAISO — A 62-year-old Porter woman faces a felony neglect charge after allegedly leaving a man with advanced Alzhiemer's disease lying unconscious on the floor of his home, records show ...

Eli Lilly invests £279M in the UK to boost life sciences, while its Alzheimer's drug, donanemab, faces European regulatory ...